About Eulysis
Eulysis is a company based in Cambridge (United States) founded in 2010. Eulysis has raised $4.8 million across 3 funding rounds from investors including Google and 43North. Eulysis operates in a competitive market with competitors including Ideal Cures, Legacy Pharma Solutions, Sanner, SCHOTT Poonawalla and Natural Capsules, among others.
- Headquarter Cambridge, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Eulysis Uk Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.8 M (USD)
in 3 rounds
-
Latest Funding Round
$3.2 M (USD), Series A
Jun 01, 2015
-
Investors
Google
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Eulysis
Eulysis has successfully raised a total of $4.8M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $3.2 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Eulysis
Eulysis has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Google and 43North.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed-stage investments are targeted by 43North in startups.
|
Locked | Locked | Locked | |
|
A technology company offering products and services, including search engine, cloud computing, advertising, email, productivity software, and more
|
Locked | Locked | Locked |
Investor details for Eulysis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Eulysis
Investment portfolio details for Eulysis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Eulysis
Detailed financials for Eulysis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eulysis Comparisons
Peer comparison for Eulysis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Eulysis
Eulysis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ideal Cures, Legacy Pharma Solutions, Sanner, SCHOTT Poonawalla and Natural Capsules, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer of pharmaceutical excipients and coatings systems for solid oral dosage forms
|
|
| Locked | Locked | Locked |
Contract pharmaceutical packaging company
|
|
| Locked | Locked | Locked |
Plastic packaging solutions for pharmaceutical products are manufactured.
|
|
| Locked | Locked | Locked |
Packaging solutions for pharmaceutical and biotech industries are provided.
|
|
| Locked | Locked | Locked |
Manufacturing and supply chain services for biopharma sector are provided.
|
Detailed competitors of Eulysis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eulysis
Complete news archive for Eulysis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eulysis
Eulysis was founded in 2010 and raised its 1st funding round 4 years after it was founded.
Eulysis is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Eulysis is a funded company, having raised a total of $4.8M across 3 funding rounds to date.
Eulysis was founded in 2010 and is located in Cambridge, United States. Operations center on diabetes care within the healthcare sector, where services including dietary guidance, exercise programs, and medical oversight are delivered. A specialized diet kitchen is maintained to advise on suitable food selections. Educational materials are distributed to support patient self-management and overall health control.
Eulysis's top competitors include Legacy Pharma Solutions, Natural Capsules and SCHOTT Poonawalla.